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Abstract
Social deprivation negatively affects health outcomes but receives little attention in obstetric risk selection. We investi-
gated whether a combination of (1) risk assessment focused on non-medical risk factors, lifestyle factors, and medical risk
factors, with (2) subsequent institution of risk-specific care pathways, and (3) multidisciplinary consultation between care
providers from the curative and the public health sector reduced adverse pregnancy outcomes among women in selected
urban areas in the Netherlands. We conducted a cluster randomised controlled trial in 14 urban municipalities across the
Netherlands. Prior to the randomisation, municipalities were ranked and paired according to their expected proportion of
pregnant women at risk for adverse outcomes at birth. The primary outcome was delivery of a preterm and/or small for
gestational age (SGA) baby, analysed with multilevel mixed-effects logistic regression analysis adjusting for clustering and
individual baseline characteristics. A total of 33 community midwife practices and nine hospitals participated throughout
the study. Data from 4302 participants was included in the Intention To Treat (ITT) analysis. The intervention had no
demonstrable impact on the primary outcome: adjusted odds ratio (aOR) 1.17 (95% CI 0.84–1.63). Among the secondary
outcomes, the intervention improved the detection of threatening preterm delivery and fetal growth restriction during
pregnancy [aOR 1.27 (95% CI 1.01–1.61)]. Implementation of additional non-medical risk assessment and preventive
strategies into general practices is feasible but did not decrease the incidence of preterm and/or SGA birth in the index
pregnancy in deprived urban areas.
Trial registration Netherlands National Trial Register (NTR-3367).
Keywords Pregnancy  Risk assessment  Risk factors  Epidemiology  Prevention
Introduction
Social deprivation negatively affects health outcomes. This
association is already apparent before birth and extends
into early childhood [1–4]. In addition to the negative
impact of medical and obstetric risk factors, multiple
studies have shown a strong association between non-
medical risk factors and adverse pregnancy outcomes. Key
examples of such risk factors include low socioeconomic
status (SES), living in a deprived neighbourhood,
ineffective social integration into society, smoking, and
psychosocial stressors [5–8]. The increased prevalence of
non-medical risk factors and the accumulation of such
factors are responsible for at least part of the overrepre-
sentation of adverse pregnancy outcomes in deprived urban
areas within high-income countries [7, 9]. Risk assessment
and subsequent implementation of preventive measures in
antenatal health care with the aim to reduce adverse
pregnancy outcomes should, therefore, take both medical
and non-medical risk factors into account. However, cur-
rent risk selection during pregnancy mainly focuses on
medical risks, and integration between the curative and
public health sector is scarce [10].
In the Netherlands, obstetric risk selection is based on
the ‘List of Obstetric Indications’(LOI), which specifies
manifest conditions that define a low, medium, or high-risk
pregnancy. These conditions are single medical or obstetric
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risk factors, that indicate whether a patient’s care during
pregnancy or parturition is to be supervised by a commu-
nity midwife or an obstetrician [11].
The R4U scorecard is a comprehensive risk assessment
tool which can, in addition to the LOI, be used by obstetric
care providers to identify psychological, social, lifestyle,
obstetric and non-obstetric care related factors [12]. The
total R4U score is strongly associated with adverse preg-
nancy outcomes and shows a clear gradient across cate-
gories of SES and ethnicity [13].
We conducted a cluster randomised controlled trial (C-
RCT) to assess the effectiveness of using the R4U score-
card in conjunction with institution of appropriate care
pathways and multidisciplinary consultations, to reduce the
incidence of adverse pregnancy outcomes. The study was
conducted among pregnant women in selected urban areas
in the Netherlands with an overrepresentation of adverse
pregnancy outcomes [14–16]. This study is part of the
‘Healthy pregnancy 4 All’ (HP4All) programme, a
nationwide study evaluating strategies to improve preg-
nancy outcomes, in particular among deprived populations
[14].
Methods
Trial design
We conducted a C-RCT in 14 municipalities in the
Netherlands. The Daily Board of the Medical Ethics
Committee Erasmus MC approved the study (METC
2012-322). The study protocol was peer-reviewed and
published, and was registered at the Netherlands National
Trial Register (NTR-3367) [17]. Municipalities were
selected based on multiple criteria: (1) size (having more
than 70,000 inhabitants), (2) disproportionally high
prevalence of risk factors for adverse pregnancy outcomes
(high and/or low maternal age, primiparity, non-western
ethnicity, and low SES), (3) a high incidence of adverse
pregnancy outcomes (delivery of a small for gestational
age baby (SGA), preterm delivery, and perinatal mortality
[mortality from the 22th week of gestation until 7 days
postnatally)], and (4) a higher than average case-fatality
rate [14]. The case-fatality rate is the proportion of peri-
natal mortality amongst neonates with a so-called ‘BIG4’
condition: congenital anomalies, preterm birth, SGA, and/
or an Apgar score below seven at five minutes after birth
[18]. A more detailed description of the selection process
of municipalities has been published before [14]. All
community midwife practices and hospitals located in the
participating municipalities were invited to participate in
the trial.
Participants
The 14 selected municipalities were divided into ten
clusters; five municipalities in the northern part of the
Netherlands were merged into one cluster due to the
intended formation of a so called ‘obstetric collaborative
network’ in that area [17]. An obstetric collaborative net-
work is an inter-professional care system in which com-
munity midwives, obstetricians, and maternity care
providers share local guidelines and protocols. All women
with a singleton pregnancy living in a selected municipality
and booking their first antenatal visit at one of the partic-
ipating community midwife practices or at a participating
hospital were eligible for this trial. Exclusion criteria
included an obstetric emergency situation or being in
labour during the initial visit.
Intervention
In the intervention clusters, participating obstetric care
providers used the R4U scorecard as a risk assessment tool
at the first antepartum visit. They did so in addition to their
conventional risk assessment approach (LOI-based). The
R4U scorecard guided coordination of antepartum care
through systematic risk assessment for medical and non-
medical risk factors for adverse pregnancy outcomes
(Online Resource 1). To increase uniformity in questioning
within the R4U, a ‘script’ text was formulated for each
separate item as a literal text. A positive response indicated
presence of the risk factor. Risk factors were selected after
a broad literature search and complemented with detailed
epidemiological information of prevalence and risk esti-
mates derived from well-documented large birth cohort
studies [17]. Risk factors were weighted based on their
relative risk for adverse pregnancy outcomes [12]. Scores
for individual risk factors were added up to form a total
score (range R4U 0-98). A predefined cut-off score was
based on data from a pilot study in the Netherlands from
2010 to 2011; a score of 16 points or higher was selected to
identify women in the upper 20% of risk scores [19]. In the
current study, a cumulative R4U score of C 16 points
implied a follow-up action via a case-based discussion in a
multidisciplinary setting. In addition, the institution of
appropriate individual care pathways was guided by par-
ticular single, or a set of multiple, risk factors (Fig. 1).
Case-based multidisciplinary consultations involved
community midwives, obstetricians and other healthcare
professionals, such as paediatricians or social workers.
With this approach optimal linkage was sought between the
public health sector and the curative care sector. The aim of
the meeting was to agree on a customised antepartum
policy for each individual patient [17]. Obstetric care
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providers were in addition allowed to discuss participants
in these discussions to their own discretion, independently
of the cumulative R4U score. As a result, participants with
relevant individual risk factors could also be discussed
when the cumulative score was below 16 (Fig. 1).
Prior to start of the study, 28 templates of care pathways
were developed based on the medical and non-medical risk
factors incorporated in the R4U. These templates consisted
of a set of steps a healthcare professional was advised to
take in an attempt to reduce the potential contribution of
one or more risk factors to developing an adverse preg-
nancy outcome. As such, each care pathway could, for
example, direct the user to a specific health care provider,
or to a health care organisation, public health care organ-
isation, or an office for legal or financial support. When
there was existing evidence for interventions to address
modifiable risk factors this was used for the contents of the
pathway. To enhance the efficiency of the care provided,
care pathways are explicit as to which caregiver will be
responsible. To facilitate local adaptation of this new way
of organising antenatal care, details of the care pathways
were discussed during meetings with community mid-
wives, obstetricians, social workers, and a city council
representative. In these meetings the templates for the
pathways were complemented with the availability of local
facilities and health insurance agreements, and refined
through direct interaction with relevant local health care
providers, and organisations. In addition, the introduction
of organized meetings to customize care pathways induced
a change in the mutual professional relationship between
care providers of different echelons. An example of a care
pathway, in this case for psychosocial risk factors, is added
in the Online Resource 2.
Controls
In the control clusters, an existing screening instrument
(LOI), which focuses on identification of single, manifest
obstetric and medical risks, was used, combined with
individual care according to local protocols. The LOI
Fig. 1 Trial design
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distinguishes between a low, medium, or a high risk
pregnancy based on anticipated third trimester and labour
complications [11]. Low risk indications allow women to
choose the preferred place of delivery (i.e. home birth,
birth centre, hospital birth), which is supervised by an
independent community midwife. Women with medium
risk pregnancies should deliver in a hospital supervised by
a midwife, whereas women with high risk pregnancies are
supervised by an obstetrician during pregnancy and hos-
pital delivery [11]. If the risk changes from a low or
medium risk to a high risk, the woman is referred from
primary to secondary or tertiary care, even during labour
(Fig. 1).
Outcomes
Baseline characteristics were collected via a questionnaire
that was filled out by participants after the first antepartum
visit, generally around ten to 12 weeks of gestational age.
The following characteristics were collected: maternal age
at inclusion, parity, ethnicity (western versus non-western
based on maternal country of birth and classified according
to Statistics Netherlands), single motherhood, maternal
SES (based on the classification by the Netherlands Insti-
tute of Social Research to all postal code areas, and divided
into three centile groups: low\ 20, medium 20-80, and
high[ 80) [20], maternal BMI prior to conception (cate-
gorised into low\ 20, normal 20–29, and high 30 and
more), maternal education [(highest completed education
categorised into low: primary school, special education,
pre-vocational (secondary) education, junior general sec-
ondary education; middle: senior general secondary edu-
cation, pre-university education, senior secondary
vocational education; and high: higher professional edu-
cation, university education)], smoking during pregnancy
(yes/no), and risk factors derived from the obstetric history
(previous SGA baby, previous preterm delivery).
Perinatal outcome data was collected by a member of
the research team 6 weeks after a participant gave birth
from medical charts of community midwives and
obstetricians.
All predefined outcomes regarding the effectiveness of
this intervention pertain to the participant level. The pri-
mary study outcome was: delivery of a preterm (i.e. before
37 weeks of gestation) and/or SGA baby (birth weight
below the 10th centile adjusted for parity, gestational age,
and gender, based on the Dutch reference curves [21])
together referred to as ‘BIG2’.
Secondary outcomes were: the detection of fetal growth
restriction during pregnancy (defined as fetal growth below
the 10th centile for gestational age) and/or threatening
preterm birth during pregnancy (defined by the detection
of, and any action taken by an obstetric care provider, after
suggestive symptoms of preterm labour), any referral to
non-obstetric health care providers during pregnancy used
as a proxy for involvement (regardless of referral within
the care pathways), any referral to preventive care organ-
isations during pregnancy used as a proxy for involvement
(regardless of referral within the care pathways), maternal
mortality, unexpected SGA (babies born SGA under
supervision of a community midwife), unexpected preterm
birth (babies born preterm under supervision of a com-
munity midwife), birth asphyxia (an Apgar score below
seven at 5 min after birth was used as a proxy), neonatal
admission to an intensive care unit, and perinatal mortality
(mortality from the 22th week of gestation until 7 days
postnatally).
Two secondary outcome measures, as defined in the
initial protocol were not analysed, as these outcomes were
not considered to be potentially sensitive to a postcon-
ceptional intervention. These were: ‘prevalence of general
risk factors’ (defined as: pre-existing chronic disease, folic
acid use, and medication use) and ‘congenital anomalies’.
Among a sub-cohort we assessed participants’ and
health care providers’ satisfaction, and efficacy of imple-
mentation of the intervention; these findings are reported
elsewhere [22].
Sample size
Calculation of sample size was based on the presumed
effect of the intervention on the primary outcome, and a
two-group comparison based on the combined prevalence
of preterm birth and SGA in the Netherlands. The inter-
vention was implemented at the municipality level (clus-
ter), while the intervention effect was measured at the
participant level. To account for clustering of participants
within municipalities, the sample size was multiplied by a
Variance Inflation Factor (VIF) of 2.06, calculated with the
formula of Donner et al. [23].
In the selected clusters the average incidence of the
primary outcome before start of the study (2000–2008) was
16.7%; we hypothesised that the intervention would lead to
a decline towards 13% [17]. At an alpha of 0.05 and 80%
power, we required 700 participants per cluster, or 3500
participants in each arm. The pre-defined stopping rule was
based on the end of the HP4All study period (July 2015).
Randomisation
We randomised at the level of the clusters. Before the
randomisation procedure, municipalities were ranked
according to their expected percentage of pregnant women
at risk for a ‘BIG2’ outcome at birth. Expected proportions
were based on incidence rates from 2000–2008 derived
from the Netherlands Perinatal Registry. Municipalities
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were then paired based on this ranking. The random
number generator in R version 2.7.1 was used to assign one
of the municipalities in each pair to the intervention arm.
The other municipality of that pair was then assigned to the
control arm. An independent statistician, who was not
involved in executing the study, carried out the randomi-
sation process. The randomisation at cluster level, instead
of the randomisation of midwife practices or hospitals, was
necessary to avoid contamination as community midwives
and obstetricians generally work closely together in
obstetric collaborative networks. Obstetric care providers
within each cluster were informed and educated with
knowledge of the outcome of the randomisation process.
Blinding of obstetric care providers was not possible given
the nature of the intervention. Allocation concealment of
participants was set out by exclusively foreseeing in study
information about the situation that was assigned to a
specific cluster. As a result, participants were unaware of
the randomised design of the study.
Statistical methods
The impact of the intervention on the primary and sec-
ondary outcomes was analysed using multilevel mixed-
effects logistic regression analysis (with an assumed ran-
dom effect for each cluster). Multiple imputation using
chained equations was used to account for missing data in
baseline characteristics. Both predictor and outcome vari-
ables were included to inform the multiple imputation
process, forming 15 datasets. Results across the sets were
combined using Rubin’s Rules [24]. No interim analysis
was performed. Analyses were performed according to the
ITT principle. We included the following covariates in our
models: age, ethnicity, BMI prior to pregnancy, SES, sin-
gle motherhood, smoking during pregnancy, and obstetric
history (previous SGA baby and/or previous preterm
delivery). To account for over-fitting we only analysed
secondary outcomes when there were more than ten events
in the two groups. Statistical analysis was performed using
Stata SE (version 14). Statistical significance was accepted
at p\ 0.05 (two-sided).
Sensitivity analyses
Per protocol analysis
During the trial not all participants in the intervention
clusters were screened using the R4U. Therefore, a sensi-
tivity analysis was performed using a per protocol
approach to investigate whether this affected the effect
estimates.
Fig. 2 Flow diagram according to CONSORT statement
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Table 1 Baseline characteristics of participants
Intervention (n = 2269) Control (n = 2033)
Maternal characteristics
Age category (years) N % N %
\ 20 16 0.71 17 0.89
20–35 1685 74.33 1431 71.08
[ 35 566 24.97 565 28.10
Missing 2 0.09 20 0.98
Ethnic origin
Western 2020 89.70 1736 85.77
Non-western 232 10.30 288 14.24
Missing 17 0.75 9 0.44
Smoking during pregnancy
No 1230 81.35 1294 87.79
Yes 282 18.65 182 8.99
Missing 757 33.36 557 27.40
Single mother
No 1967 95.35 1439 87.14
Yes 96 4.65 46 3.10
Missing 206 9.08 548 26.98
Family income net (euros/month)
\ 1000 116 7.89 106 7.37
1000–1499 233 15.85 176 12.23
1500–1999 203 13.81 160 11.12
2000–2499 228 15.51 195 13.55
2500–2999 239 16.26 204 14.18
[ 3000 451 30.68 598 41.56
Missing 799 35.21 594 29.22
Educational level
Low 199 13.17 179 12.30
Medium 672 44.47 463 31.80
High 640 42.36 814 55.91
Missing 758 33.41 577 28.38
Socioeconomic status
Low (\ P20) 1485 72.79 862 46.59
Medium (P20–P80) 457 22.40 731 39.51
High ([P80) 98 4.80 257 13.89
Missing 229 10.09 183 9.00
BMI at start pregnancy
BMI\ 25 1021 45.20 1098 54.30
BMI 25–35 943 41.74 736 36.40
BMI[ 35 295 13.06 188 9.30
Missing 10 0.44 11 0.54
Prior pregnancy characteristics
Previous SGA baby
Nulliparous 1079 47.55 985 48.50
No 700 36.12 860 92.18
Yes 159 8.20 73 7.82
Missing 331 14.59 115 10.97
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Enrichment of the control clusters
During the study, there was a substantial lag in participant
recruitment in the control clusters. Following an ad-hoc
study group meeting, a decision was made to ‘enrich’ the
control arm with pregnancies included retrospectively from
participating practices to a total of 700 participants per
cluster. Retrospective pregnancy data was extracted from
digital medical charts in participating community midwife
practices. Inclusion criteria were identical to the prospec-
tive inclusion. Demographic characteristics of the
prospectively and retrospectively included participants in
the control arm were compared and the potential differ-
ences between the groups were explored.
Results
Participant flow
Five clusters, including eight hospitals and 20 community
midwife practices, were included in the intervention arm,
and five clusters (eight hospitals and 16 community mid-
wife practices) served as controls (Fig. 2). Complete data
regarding baseline characteristics was available for 2486 of
2872 (86.8%) participants in the intervention arm and 2227
of 2424 (91.9%) participants in the control arm (Fig. 2).
We excluded participants who had a miscarriage (125 and
72, for the intervention and control group, respectively).
Primary outcome data was unavailable for 92 (3.2%) par-
ticipants in the intervention arm and 122 (5.0%) partici-
pants in the control arm (Fig. 2). Accordingly, 4302
participants were included in the ITT analyses.
In the intervention arm, 77.3% of participants were
actually screened using the R4U. Of all participants
screened 7% had a sum score of 16 or higher, and 50% of
participants with an R4U cut-off score above 16 had a
registered multidisciplinary consultation.
Baseline data
Table 1 presents the maternal and pregnancy characteris-
tics at the individual level of all prospectively included
participants, by treatment allocation. Online Resource 3,
presents the same characteristics at cluster level. Partici-
pants in the control arm had a higher income per month, a
higher educational level and a higher SES as compared to
those in the intervention arm. Participants who did not have
data on the primary outcome did not differ importantly
from those included in the ITT analysis (Online Resource
4).
Impact of the intervention on primary
and secondary outcomes
The combined primary outcome delivery of a preterm and/
or a SGA baby (BIG2) occurred in 16.3% of participants in
the intervention arm and in 13.2% of participants in the
control arm [unadjusted odds ratio OR 1.34 (95% CI
0.92–1.94); Table 2 and Online Resource 5]. The inter-
vention had no demonstrable impact on the primary out-
come in multivariable analysis: adjusted odds ratio (aOR)
1.17 (95% CI 0.84–1.63) (Table 3). The intervention
improved the detection of threatening preterm delivery and
fetal growth restriction during pregnancy compared to the
control arm: aOR 1.27 (95%CI 1.01–1.61), but had no
Table 1 (continued)
Intervention (n = 2269) Control (n = 2033)
Previous preterm delivery
Nulliparous 1079 47.55 985 48.50
No 824 41.78 883 93.94
Yes 69 3.50 57 6.06
Missing 297 13.09 108 10.31
Pregnancy characteristics
Parity
Nulliparous 1079 47.55 985 48.50
Multiparous 1190 52.45 1048 51.60
Missing 0 0 0 0
Values are expressed as numbers (first) and percentage (second). Percentages of categorised values are percentages of non-missing cases.
Missing percentages are percentages of total cases
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significant impact on any other secondary outcomes
(Table 3).
Sensitivity analyses
Demographic characteristics differed significantly between
the prospectively and retrospectively included participants
in the control arm (Online Resource 6). Prospectively
included participants were more often of western ethnic
origin, had a higher educational level, and a higher SES.
Due to this important heterogeneity we decided not to
conduct any additional analyses including data from the
retrospectively included participants.
Per protocol analysis
The effect estimates did not change materially when per-
forming a per protocol analysis as compared to the inten-
tion to treat analysis (Table 4).
Discussion
By introducing one single tool for additional risk assess-
ment in all tiers of the Dutch obstetric care system we
achieved uniformity in risk assessment among 33 com-
munity midwife practices and nine hospitals in 14 urban
municipalities in the Netherlands [25]. The combination
with subsequent institution of care pathways and multi-
disciplinary consultations further promoted uniformity in a
more proactive and preventive approach regarding medical
and non-medical risk factors during pregnancy. Hereby the
traditional risk assessment during pregnancy, aimed at
recognising primarily medical risk factors for complica-
tions during labour, shifted towards the first trimester and
created a larger window of opportunity for prevention.
However in this C-RCT, this combined intervention had no
demonstrable impact on preterm and/or SGA birth.
Health inequalities depend on a person’s social, eco-
nomic, and political environment. These environments are
shaped by policies, which makes them amenable to change
[26]. Our trial is part of the overall HP4All research pro-
gramme designed to evaluate the effectiveness of inter-
ventions, and their associated preventive strategies, in
decreasing health inequalities in pregnancy outcomes [14].
To accomplish implementation of such a programme,
interventions should contain a flexible approach that allows
for adaptation. Such adaptations stimulate the implemen-
tation process and increase sustainability [18]. However,
the same flexibility may also have influenced our results.
For example, all participating caregivers, including those
belonging to the control arm, were educated prior to the
start of the program about the importance of non-medical
risk factors in relation to adverse pregnancy outcomes.
Such adaptations may have resulted in an unintended spill
over of intervention effects in the control arm.
This study also has other limitations. Firstly, the inten-
ded inclusion of 7000 participants was not achieved within
the study’s time frame, and there was a wide variation in
sample size among clusters. Secondly, despite the fact that
the HP4All programme was set out in the most deprived
neighbourhoods of the Netherlands, the participants in this
study had an educational level and family income above
the national average, suggesting a substantial degree of
Table 2 Primary and secondary outcomes at individual level
Intervention (n = 2269) Control (n = 2033)
% %
Primary outcomes
BIG2
Yes 371 16.35 269 13.23
Secondary outcomes
Maternal
Referral to non-obstetric health care providers
Yes 523 26.02 568 29.82
Missing 259 11.41 128 6.30
Referral to preventive care organisations
Yes 129 6.59 74 4.34
Missing 311 13.71 327 16.08
BIG2 detected during pregnancy
Yes 220 10.59 150 7.69
Missing 192 8.46 83 4.08
Delivery
Unexpected SGA (delivery of SGA baby in first tier)
Yes 44 1.95 35 1.73
Missing 7 0.31 11 0.54
Unexpected preterm (preterm delivery in first tier)
Yes 4 0.18 3 0.15
Missing 10 0.44 13 0.64
Neonatal
Preterm delivery
Yes 165 7.28 94 4.63
Small for gestational age
Yes 229 10.09 186 9.15
Perinatal mortality
Yes 15 0.67 8 0.40
Missing 35 1.54 10 0.49
Primary and secondary outcomes at individual level, categorised in
primary (delivery of a preterm and/or a SGA baby, referred to as
‘BIG2’) and secondary outcomes (maternal, delivery, and neonatal).
Values are expressed as numbers (first) and percentage (second).
Percentages of categorised values are percentages of non-missing
cases. Missing percentages are percentages of total cases
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selection bias. As a result, whereas based on previous
research we expected 20% of participants to have an R4U
score of 16 or higher, only 7% fulfilled this criterion in the
final sample. Thirdly, our results show that not all partic-
ipants received the intervention as intended. In the inter-
vention arm, 77.4% of all participants were assessed using
the R4U scorecard. Of participants with a cut-off score
higher than 16, only 50% had a registered multidisciplinary
consultation. In addition, the process evaluation of this
study, based on Saunders’ 7-step method, showed that only
half of the participating municipalities met the criteria for
full implementation of the risk assessment program [22].
The combination of not achieving the intended sample size,
having fewer participants with a high-risk score according
to the pre-defined cut-off, and the above mentioned dilution
of the intervention, reduced the power of this study to
identify effectiveness.
Fourthly, there were differences in demographic char-
acteristics between participants in the intervention arm and
participants in the control arm (Table 1). Participants in the
intervention arm had a lower income per month, a lower
educational level and a lower SES as compared to those in
the control arm. This heterogeneity could be explained by a
selection bias, which is a well-recognised phenomenon in
C-RCTs [27, 28]. Participants were recruited after the
clusters had been randomised. Obstetric care providers had
knowledge of whether participants belonged to the inter-
vention or the control arm and this could have affected the
types of participants they recruited. Health care providers
in the intervention arm may have included more partici-
pants with a higher risk for adverse pregnancy outcomes, or
in other terms, participants more suitable for ‘active man-
agement’. In the control arm this selection likely led to an
inclusion of participants with a favourable risk profile. This
is further substantiated by the observation that prospec-
tively included participants were more often of western
ethnic origin, had a higher educational level, and a higher
SES than retrospectively included participants, who were
more likely to represent an unbiased sample (Online
Resource 6). Although in our analysis we adjusted for
known potential confounders, unmeasured confounders
could have been imbalanced too and as such may have
influenced the results of our analysis.
Despite careful theoretical planning, cluster randomised
controlled trials are known to be vulnerable to risk of bias,
specifically, bias in selection of participants [27, 29, 30].
Table 3 Impact of intervention on primary and secondary outcomes
OR (95% CI)
Unadjusted Adjusted
Primary outcomes
BIG2 (n = 4002) 1.34 (0.92–1.94) 1.17 (0.84–1.63)
Secondary outcomes
Referral to non-obstetric health care providers (n = 3748) 0.82 (0.54–1.24) 0.79 (0.51–1.23)
Referral to preventive care organisations (n = 3568) 1.17 (0.43–3.21) 0.96 (0.36–2.54)
Fetal growth restriction/preterm birth detected in pregnancy (n = 3830) 1.40 (1.03–1.92) 1.27 (1.01–1.61)
Unexpected SGA (n = 3989) 1.21 (0.69–2.13) 1.28 (0.63–2.62)
Perinatal mortality (n = 3975) 1.70 (0.72–4.02) 1.33 (0.51–3.44)
Numbers are aOR and 95% confidence interval
Table 4 Per protocol sensitivity
analysis primary and secondary
outcome variables
Per protocol analysis aOR (95% CI)
Primary outcomes
BIG2 (n = 3564) 1.10 (0.77–1.57)
Secondary outcomes
Referral to non-obstetric health care providers (n = 3438) 0.79 (0.51–1.22)
Referral to preventive care organisations (n = 3282) 0.95 (0.37–2.42)
Fetal growth restriction/preterm birth detected in pregnancy (n = 3618) 1.32 (0.96–1.80)
Unexpected SGA (n = 3618) 1.04 (0.48–2.29)
Perinatal mortality (n = 3539) 1.29 (0.47–3.53)
Numbers are aOR and 95% confidence interval
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Our experience has implications for designing similar trials
in the future. The observed inclusion bias in this trial is
mostly based on a recruitment bias. Blinding the recruiter
of participants for allocation could potentially have
diminished this bias. In our trial, participants were recrui-
ted by their health care providers, who were also respon-
sible for subsequent pregnancy care, making blinding
impossible. This may be addressed by separating partici-
pant inclusion from participant care in future studies.
Moreover, researchers of C-RCTs may consider conduct-
ing an interim analysis, which could potentially have
detected the differences in baseline characteristics between
the intervention and the control arm. Such an analysis
would potentially also have been able to detect the addi-
tional issues that eventually caused a dilution of the
intervention effect, allowing these to be addressed during
the course of the trial.
Despite the above-mentioned limitations, our study
shows that implementation of additional non-medical risk
assessment and preventive strategies into general practices
are feasible. It did, however, not decrease the incidence of
adverse perinatal outcomes in the index pregnancy in
deprived urban areas.
Extended screening for populations at risk, together with
improved collaboration between the curative and public
health sector in patient-tailored care, is a start in estab-
lishing equity-oriented strategies during pregnancy. How-
ever, an intensive research programme as HP4All should
ultimately seek to serve pregnant women. Serving in these
interventions means detecting those with the greatest health
needs, and help them to find the power to direct resources
towards those needs. In this perspective, future research in
this field should elucidate what empowers pregnant women
and which specific resources they need to address their
health needs. Effectiveness in this regard, could include
value based outcome measures, rather than focusing merely
on health outcomes.
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